Japan· JP-6343433A2015
ポリエチレングリコール処理抗破傷風人免疫グロブリン
A medicinal product containing ポリエチレングリコール処理抗破傷風人免疫グロブリン, registered in Japan, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ポリエチレングリコール処理抗破傷風人免疫グロブリン
- Manufacturer
- —
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ポリエチレングリコール処理抗破傷風人免疫グロブリン in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyIGANTET*1 siringa IM 250 UI 1 mlINSTITUTO GRIFOLS S.A.
- United KingdomLiberim T 250unit solution for injection vialsScottish National Blood Transfusion Service
- BelgiumTetagam P 250 IU/mlCSL Behring
- CzechiaIGANTETInstituto Grifols, S.A., Barcelona
- SpainGAMMA ANTI-TETANOS GRIFOLS 250 U.I. SOLUCION INYECTABLE EN JERINGA PRECARGADAInstituto Grifols S.A.
- PolandIgantet 250Instituto Grifols S.A.
- GermanyTetagam PCsl Behring Gmbh
- SwitzerlandTetagam P, InjektionslösungCSL Behring AG
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Tetagam P
- Belgium · Tetagam P
- Czechia · Igantet
- Germany · Tetagam P
- Spain · Gamma Anti-Tétanos Grifols
- France · Gammatetanos
- United Kingdom (Northern Ireland) · Human Tetanus Immunoglobulin Bio Products Laboratory
- Greece · Igantet, Tetagam P
- Hungary · Tetagam P
- Ireland · Tetagam P
- Italy · Igantet, Tetanus Gamma
- Malta · Tetagam P, Tetanus Gamma Kedrion
- Netherlands · Tetagam P
- Poland · Igantet
- Portugal · Gamaglobulina Humana Antitetânica Pasteurizada Grifols, Tetagam P
- Slovenia · Tetagam P
- Slovakia · Igantet
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d16d1fc8-dcfb-4ebd-9da9-616defe17b90 GET /v1/drugs/d16d1fc8-dcfb-4ebd-9da9-616defe17b90?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１，５００国際単位１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "6343433A2015",
"category": "注射薬",
"price_yen": null,
"generic_name": "ポリエチレングリコール処理抗破傷風人免疫グロブリン",
"product_name_jp": null,
"therapeutic_class": "6343",
"transitional_expiry": null
}See everything about ポリエチレングリコール処理抗破傷風人免疫グロブリン.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.